Podcast

Pharmacy Focus: Psychedelic Pharmacy - An Exploration of Psychedelic Medicines in Palliative Care

For patients facing end-of-life care, psychedelic medicines may offer a chance to feel connected with themselves and others during such a difficult time.

This month, we spoke with Paul Thielking, MD, who has been investigating the use of psychedelic medicines in palliative care environments. For patients facing end-of-life care, Thielking said psychedelic medicines may offer a chance to feel connected with themselves and others during such a difficult time.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Monoclonal antibodies are used to treat lung cancer. They are created in a lab and designed to target specific proteins on cancer cells, stopping them from growing and dividing.
Gene therapy in lung cancer (LC) - isometric view 3d illustration
Related Content
World Lymphoma Awareness Day
September 16th 2025

World Lymphoma Awareness Day Highlights Innovation in Patient Care

Alexandra Gerlach, Associate Editor
ESC 2023 Highlights: Insights on ALONE-AF and AQUATIC Trials
September 16th 2025

ESC 2023 Highlights: Insights on ALONE-AF and AQUATIC Trials

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
White pill bottle with "doctor recommended" label on gray background | Image Credit: SERHII | stock.adobe.com
September 16th 2025

FDA Cracks Down on Deceptive Prescription Drug Advertising

Danielle Valletti, Assistant Editor
Pharmacy focus oncology Edition, radon and lung cancer
September 16th 2025

A Silent Killer: Unmasking Radon’s Link to Lung Cancer

Alexandra Gerlach, Associate Editor
Abstract luminous DNA molecule. Genetic and gene manipulation concept. Cut of replacing part of a DNA molecule. Medicine. Innovative in science. Medical science and biotechnology.
September 16th 2025

Addressing Adverse Outcomes and Enhancing Patient Care in Gene Therapy

Luke Halpern, Assistant Editor
Panel of health care professionals -- Image credit: Africa Studio | stock.adobe.com
September 16th 2025

Decoding Most Favored Nation: Expert Insights on the Impacts to Patients, Pharma, and Innovation

Brian Corvino Neal Masia, PhD Ali Pashazadeh George Van Antwerp, MBA Ned Milenkovich, PharmD, JD Gillian McGovern, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.